Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Advances in Therapy
|
June 19, 2017
When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
Nektarios Oraiopoulos, William C N Dunlop
Dimensions in Health Service
|
March 1, 1980
Innovative drug distribution saves time and money
N Dunlop, J Watson, G Byrne
Saudi Journal of Anaesthesia
|
October 2, 2023
A systematic review of predictive accuracy via c-statistic of preoperative frailty tests for extended length of stay, post-operative complications, and mortality
Richard A N Dunlop, André Van Zundert
Dimensions in Health Service
|
October 1, 1983
Measuring workload--a nursing WISH
N Dunlop, J Watson, G A Bryne
AIDS Research and Human Retroviruses
|
July 1, 1991
Cross-neutralizing antibodies to HIV-1 in mice after immunization with gp160 iscoms. Dissection of the immune response
L Akerblom, P Nara, N Dunlop, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1990
Heat-labile, complement-like factor(s) of animal sera prevent(s) HIV-1 infectivity in vitro
S Hosoi, T Borsos, N Dunlop, et al.
Biotechnology Therapeutics
|
January 1, 1993
HIV experimental vaccines based on the iscom technology using envelope and GAG gene products
L Akerblom, P Nara, N Dunlop, et al.
Advances in Therapy
|
September 7, 2015
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
Ashok Jha, Alex Upton, William C N Dunlop, et al.
Fish Physiology and Biochemistry
|
November 7, 2013
Characterization of the microsomal epoxide hydrolase of hepatic microsomes of the common dab,Limanda limanda
A McCord, N Dunlop, R M Stagg, et al.
Health Policy (Amsterdam, Netherlands)
|
March 24, 2018
Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience
William C N Dunlop, Alexandra Staufer, Pierre Levy, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Advances in Therapy
|
June 19, 2017
When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
Nektarios Oraiopoulos, William C N Dunlop
Dimensions in Health Service
|
March 1, 1980
Innovative drug distribution saves time and money
N Dunlop, J Watson, G Byrne
Saudi Journal of Anaesthesia
|
October 2, 2023
A systematic review of predictive accuracy via c-statistic of preoperative frailty tests for extended length of stay, post-operative complications, and mortality
Richard A N Dunlop, André Van Zundert
Dimensions in Health Service
|
October 1, 1983
Measuring workload--a nursing WISH
N Dunlop, J Watson, G A Bryne
AIDS Research and Human Retroviruses
|
July 1, 1991
Cross-neutralizing antibodies to HIV-1 in mice after immunization with gp160 iscoms. Dissection of the immune response
L Akerblom, P Nara, N Dunlop, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1990
Heat-labile, complement-like factor(s) of animal sera prevent(s) HIV-1 infectivity in vitro
S Hosoi, T Borsos, N Dunlop, et al.
Biotechnology Therapeutics
|
January 1, 1993
HIV experimental vaccines based on the iscom technology using envelope and GAG gene products
L Akerblom, P Nara, N Dunlop, et al.
Advances in Therapy
|
September 7, 2015
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
Ashok Jha, Alex Upton, William C N Dunlop, et al.
Fish Physiology and Biochemistry
|
November 7, 2013
Characterization of the microsomal epoxide hydrolase of hepatic microsomes of the common dab,Limanda limanda
A McCord, N Dunlop, R M Stagg, et al.
Health Policy (Amsterdam, Netherlands)
|
March 24, 2018
Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience
William C N Dunlop, Alexandra Staufer, Pierre Levy, et al.
Page
of 4